Selecta Biosciences, Inc

(NASDAQ:SELB)

Latest On Selecta Biosciences, Inc (SELB):

Date/Time Type Description Signal Details
2023-05-05 05:09 ESTNewsSelecta Biosciences, Inc. (SELB) Q1 2023 Earnings Call TranscriptN/A
2023-05-04 16:25 ESTNewsSelecta Biosciences GAAP EPS of -$0.14 misses by $0.05, revenue of $5.9M misses by $6.24MN/A
2023-04-08 14:57 ESTNewsSelecta's New Gout Data Strengthens Evidence Of Inadequate DifferentiationN/A
2023-03-21 09:36 ESTNewsSelecta surges ~20% as gout drug SEL-212 meets main goal in 2 phase 3 trialsN/A
2023-03-14 09:38 ESTNewsMurky Forecast For Selecta Biosciences' SEL-212 In Treating Chronic Refractory GoutN/A
2023-03-02 21:30 ESTNewsSelecta Biosciences GAAP EPS of $0.04 beats by $0.11, revenue of $16.79M beats by $5.11MN/A
2023-03-02 21:29 ESTNewsSelecta Biosciences, Inc. (SELB) Q4 2022 Earnings Call TranscriptN/A
2023-03-01 16:04 ESTNewsSelecta Biosciences Q4 2022 Earnings PreviewN/A
2023-01-09 20:14 ESTNewsSelecta Biosciences stock rises 10% on license deal with Astellas for XorkN/A
2022-12-06 07:12 ESTNewsSelecta: Despite Challenges, Dissolve Topline Data Could Move The StockN/A
2022-11-28 17:34 ESTNewsSelecta Biosciences appoints Protara Therapeutics's Blaine Davis as new CFON/A
2022-11-05 18:03 ESTNewsSelecta Biosciences, Inc. (SELB) Q3 2022 Earnings Call TranscriptN/A
2022-11-03 15:02 ESTNewsSelecta Biosciences GAAP EPS of -$0.05 misses by $0.04, revenue of $20.71M misses by $4.5MN/A
2022-08-22 04:14 ESTNewsSelecta Biosciences: A Derivative Play On Gene Therapies Via ImmTOR PlatformN/A
2022-08-15 21:13 ESTNewsSelecta: ImmTOR Could Change Autoimmune Disorder Treatment LandscapeN/A
2022-08-07 08:27 ESTNewsSelecta Biosciences, Inc's (SELB) CEO Carsten Brunn on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-04 16:27 ESTNewsSelecta Biosciences GAAP EPS of $0.06 beats by $0.14, revenue of $39.3M beats by $25.52MN/A
2022-08-04 16:27 ESTNewsSelecta stock rises 13% on Q2 beat while revenue doublesN/A
2022-08-04 01:36 ESTNewsSelecta Biosciences Q2 2022 Earnings PreviewN/A
2022-06-23 01:43 ESTNewsSelecta Biosciences, Inc. (SELB) CEO Carsten Brunn on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-16 18:42 ESTNewsSelecta: Not For The Faint Of HeartN/A
2022-05-06 07:18 ESTNewsSelecta Biosciences (SELB) CEO Carsten Brunn On Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-05 09:33 ESTNewsSelecta Biosciences Q1 2022 Earnings PreviewN/A
2022-05-05 09:31 ESTNewsSelecta Biosciences GAAP EPS of $0.08 beats by $0.19, revenue of $34M beats by $20.88MN/A
2022-04-07 12:48 ESTNewsSelecta Biosciences to raise $38.7M in stock and warrants offeringN/A
2022-03-10 21:31 ESTNewsSelecta Biosciences GAAP EPS of $0.10 beats by $0.18, revenue of $29.9M beats by $12.32MN/A
2022-03-10 21:30 ESTNewsSelecta Biosciences (SELB) CEO Carsten Brunn on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-09 12:20 ESTNewsSelecta Biosciences Q4 2021 Earnings PreviewN/A
2022-01-11 01:09 ESTNewsSelecta, Gingko to collaborate on next-generation gene therapy viral capsidsN/A
2022-01-08 03:17 ESTNewsSelecta Biosciences (SELB) Investor Presentation - SlideshowN/A
2021-12-21 08:24 ESTNewsCircling Back On Selecta BiosciencesN/A
2021-11-25 03:55 ESTNewsClinical hold placed on Selecta Biosciences trial of rare genetic disorder candidateN/A
2021-11-09 16:26 ESTNewsSelecta Biosciences EPS misses by $0.09, beats on revenueN/A
2021-11-09 16:26 ESTNewsSelecta Biosciences, Inc.'s (SELB) CEO Carsten Brunn on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-08 18:21 ESTNewsSelecta says ImmTOR platform can overcome a major limitation in current gene therapyN/A
2021-11-08 18:21 ESTNewsSelecta Biosciences Q3 2021 Earnings PreviewN/A
2021-10-27 02:41 ESTNewsSelecta Biosciences announces deal for at-the-market equity offeringN/A
2021-10-27 02:39 ESTNewsSelecta Biosciences shares rise 10% after collaboration agreement with Ginkgo BioworksN/A
2021-10-26 00:58 ESTNewsSelecta Biosciences announces at-the-market equity offeringN/A
2021-10-21 16:28 ESTNewsGenovis licenses novel protease to Selecta to aid development of gene therapiesN/A
2021-10-04 12:43 ESTNewsSelecta Biosciences inks strategic licensing agreement with Takeda worth as much as $1BN/A
2021-09-30 22:16 ESTNewsSelecta Biosciences files IND for candidate for rare genetic disorderN/A
2021-09-22 05:31 ESTNewsSelecta Biosciences appoints Kevin Tan as CFON/A
2021-09-08 15:24 ESTNewsSelecta, Cyrus to collaborate on novel engineered therapeutic proteinsN/A
2021-08-12 23:58 ESTNewsSelecta Biosciences EPS beats by $0.12N/A
2021-08-12 23:58 ESTNewsSelecta Biosciences, Inc. (SELB) CEO Carsten Brunn on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-21 23:51 ESTNewsSelecta Bio shares jump 11% post-market on board director's $8.8M stock purchaseN/A
2021-07-21 23:24 ESTNewsSelecta Biosciences adds Nishan De Silva to board of directorsN/A
2021-07-21 23:20 ESTNewsSelecta Biosciences Has Multiple Shots On GoalN/A
2021-04-29 20:28 ESTNewsSelecta assumes all rights to gene therapy MMA-101 from AsklepiosN/A

About Selecta Biosciences, Inc (SELB):

Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, researches and develops nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's proprietary pipeline includes enzymes therapies, gene therapies, and other products and product candidates affected by undesired immune responses. Its lead product is SEL-212 that is in Phase III clinical trials for the treatment of chronic refractory gout, as well as develops a product candidate to treat IgA-mediated diseases, including IgA nephropathy, linear IgA bullous dermatitis, IgA pemphigus, and IgA vasculitis. The company also engages in the development of gene therapy product candidates that are in preclinical development, including MMA-101, a product candidate for the treatment methylmalonic academia; SEL-313, a product candidate to treat ornithine transcarbamylase deficiency; SEL-399, a product candidate to indicate appropriate dose of ImmTOR in humans to reduce the formation of antibodies to AAV capsids; and other products for the treatment of pompe disease, duchenne muscular dystrophy, and limb-girdle muscular dystrophy. In addition, it develops a product candidate to treat primary biliary cholangitis. The company has license and collaboration agreements with Swedish Orphan Biovitrum; Spark Therapeutics; Massachusetts Institute of Technology; Shenyang Sunshine Pharmaceutical Co., Ltd.; Asklepios BioPharmaceutical, Inc. Sarepta Therapeutics, Inc.; and IGAN Biosciences, Inc. Selecta Biosciences, Inc. was incorporated in 2007 and is headquartered in Watertown, Massachusetts.

SELB Quotes by TradingView

See Advanced Chart

General

  • Name Selecta Biosciences, Inc
  • Symbol SELB
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 43
  • Fiscal Year EndDecember
  • IPO Date2016-06-22
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://selectabio.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 30.14
  • Price/Book (Most Recent Quarter) 31.26
  • Enterprise Value Revenue 24.65
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.29
  • Next Year EPS Estimate -$0.40
  • Next Quarter EPS Estimate -$0.11
  • Operating Margin -342%
  • Return on Assets -27%
  • Revenue 16.6 million
  • Earnings Per Share -$1.85
  • Revenue Per Share $0.16
  • Gross Profit -37908000
  • Quarterly Earnings Growth 79.6%
View More

Highlights

  • Market Capitalization 510.74 million
  • EBITDA -57785000
  • Analyst Target Price $8
  • Book Value Per Share $0.10
View More

Share Statistics

  • Shares Outstanding 112.37 million
  • Shares Float 84.23 million
  • % Held by Insiders 2604%
  • % Held by Institutions 64.41%
  • Shares Short 6.93 million
  • Shares Short Prior Month 6.44 million
  • Short Ratio 2.66
  • Short % of Float 8%
  • Short % of Shares Outstanding 6%
View More

Technicals

  • Beta 1.1
  • 52 Week High $5.7
  • 52 Week Low $1.5
  • 50 Day Moving Average 4.4
  • 200 Day Moving Average 3.27
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Selecta Biosciences, Inc (SELB) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Selecta Biosciences, Inc (SELB) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-11$N/A-$0.14-$0.12-16.67%
2020-09-302020-11-05$N/A-$0.09$0.06-250%
2020-06-302020-08-06$N/A-$0.25-$0.21-21.36%
2020-03-312020-05-07$N/A-$0.21-$0.2824.68%
2019-12-312020-03-12$6.65 million-$0.28-$0.21-33.33%
2019-09-302019-11-08$N/A-$0.26-$0.3321.69%
2019-06-302019-08-08$13000-$0.37-$0.30-22.52%
2019-03-312019-05-09$10000-$0.31-$0.3512.43%
2018-12-312019-03-15$903000-$0.65-$0.707.14%
2018-09-302018-11-08$N/A-$0.71-$0.755.65%
2018-06-302018-08-08$N/A-$0.84-$0.68-22.93%
2018-03-312018-05-09$N/A-$0.71-$0.54-32.31%
2017-12-312018-03-15$17000-$0.88-$0.70-24.91%
2017-09-302017-11-07$27000-$0.66-$0.8724.44%
2017-06-302017-08-11$26000-$0.85-$0.75-13.52%
2017-03-312017-05-11$137000-$0.82-$0.56-47.32%
2016-12-312017-03-27$2.93 million-$0.77-$0.71-8.45%
2016-09-302016-11-10$1.05 million-$0.43-$0.42-2.97%
2016-06-302016-08-09$2.02 million-$0.50-$0.6725.52%

Selecta Biosciences, Inc (SELB) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Selecta Biosciences, Inc (SELB) Chart:

Selecta Biosciences, Inc (SELB) News:

Below you will find a list of latest news for Selecta Biosciences, Inc (SELB) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Selecta Biosciences, Inc (SELB) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-06-212.50.25CALL0 1182.03FALSE00
2024-06-2150CALL0 00FALSE00
2024-06-217.50CALL0 00FALSE00
2024-06-212.50PUT0 0125.91TRUE00
2024-06-2150PUT0 0310.47TRUE00
2024-06-217.50PUT0 0345.14TRUE00

Latest SELB Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST103$1.105
Jun 13, 2022 7:59 PM EST5$1.115
Jun 13, 2022 7:59 PM EST100$1.115
Jun 13, 2022 7:59 PM EST135$1.115
Jun 13, 2022 7:59 PM EST28$1.11

Selecta Biosciences, Inc (SELB) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-26SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1453687/000121390020015978/0001213900-20-015978-index.htm
2020-02-04UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1453687/000000000020001078/0000000000-20-001078-index.htm
2020-08-11UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1453687/000000000020007301/0000000000-20-007301-index.htm
2020-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1453687/000081413320000045/0000814133-20-000045-index.htm
2019-01-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000089924319002116/0000899243-19-002116-index.htm
2019-01-31SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1453687/000090514819000184/0000905148-19-000184-index.htm
2020-01-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1453687/000090514820000074/0000905148-20-000074-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1453687/000090514820000305/0000905148-20-000305-index.htm
2020-01-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1453687/000092189520000055/0000921895-20-000055-index.htm
2020-01-06SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1453687/000093583620000007/0000935836-20-000007-index.htm
2019-11-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1453687/000094787119000806/0000947871-19-000806-index.htm
2020-02-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1453687/000094787120000086/0000947871-20-000086-index.htm
2019-01-22424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1453687/000104746919000190/0001047469-19-000190-index.htm
2019-01-24424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1453687/000104746919000227/0001047469-19-000227-index.htm
2020-01-29S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1453687/000104746920000580/0001047469-20-000580-index.htm
2019-03-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000105562419000002/0001055624-19-000002-index.htm
2019-12-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000110465919074094/0001104659-19-074094-index.htm
2019-12-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000110465919075844/0001104659-19-075844-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000110465919076220/0001104659-19-076220-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000110465919076221/0001104659-19-076221-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000110465919076222/0001104659-19-076222-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000110465919076223/0001104659-19-076223-index.htm
2020-02-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1453687/000110465920010772/0001104659-20-010772-index.htm
2020-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000110465920076882/0001104659-20-076882-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000110465920081208/0001104659-20-081208-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000110465920081209/0001104659-20-081209-index.htm
2020-07-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000110465920081211/0001104659-20-081211-index.htm
2020-08-06S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1453687/000110465920091499/0001104659-20-091499-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000110465920091529/0001104659-20-091529-index.htm
2020-08-12CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1453687/000110465920093747/0001104659-20-093747-index.htm
2020-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000110465920110433/0001104659-20-110433-index.htm
2019-02-04SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1453687/000119312519027030/0001193125-19-027030-index.htm
2019-03-27SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1453687/000119312519088442/0001193125-19-088442-index.htm
2019-03-27SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1453687/000119312519088445/0001193125-19-088445-index.htm
2019-08-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1453687/000119312519227977/0001193125-19-227977-index.htm
2019-09-16SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1453687/000119312519245818/0001193125-19-245818-index.htm
2019-12-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1453687/000119312519315418/0001193125-19-315418-index.htm
2020-01-02SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1453687/000119312520000675/0001193125-20-000675-index.htm
2020-02-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1453687/000119312520033323/0001193125-20-033323-index.htm
2020-08-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1453687/000119312520214192/0001193125-20-214192-index.htm
2019-12-30SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1453687/000121390019027181/0001213900-19-027181-index.htm
2020-06-26SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1453687/000121390020015978/0001213900-20-015978-index.htm
2020-10-15SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1453687/000121390020031392/0001213900-20-031392-index.htm
2020-10-23SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1453687/000121390020033067/0001213900-20-033067-index.htm
2018-12-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000141057818000583/0001410578-18-000583-index.htm
2018-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000141057818000584/0001410578-18-000584-index.htm
2018-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000141057818000585/0001410578-18-000585-index.htm
2019-08-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000141057819000832/0001410578-19-000832-index.htm
2018-11-08S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1453687/000145368718000081/0001453687-18-000081-index.htm
2018-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368718000084/0001453687-18-000084-index.htm
2019-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000002/0001453687-19-000002-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000006/0001453687-19-000006-index.htm
2019-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000011/0001453687-19-000011-index.htm
2019-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000013/0001453687-19-000013-index.htm
2019-01-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000015/0001453687-19-000015-index.htm
2019-01-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000018/0001453687-19-000018-index.htm
2019-01-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000021/0001453687-19-000021-index.htm
2019-03-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000024/0001453687-19-000024-index.htm
2019-03-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000028/0001453687-19-000028-index.htm
2019-03-1510-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1453687/000145368719000032/0001453687-19-000032-index.htm
2019-03-25S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000036/0001453687-19-000036-index.htm
2019-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000039/0001453687-19-000039-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000043/0001453687-19-000043-index.htm
2019-04-29DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000044/0001453687-19-000044-index.htm
2019-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000052/0001453687-19-000052-index.htm
2019-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1453687/000145368719000053/0001453687-19-000053-index.htm
2019-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000056/0001453687-19-000056-index.htm
2019-06-183Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000068/0001453687-19-000068-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000069/0001453687-19-000069-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000070/0001453687-19-000070-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000071/0001453687-19-000071-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000072/0001453687-19-000072-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000073/0001453687-19-000073-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000074/0001453687-19-000074-index.htm
2019-06-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000075/0001453687-19-000075-index.htm
2019-06-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000078/0001453687-19-000078-index.htm
2019-07-173Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000081/0001453687-19-000081-index.htm
2019-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000082/0001453687-19-000082-index.htm
2019-07-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000084/0001453687-19-000084-index.htm
2019-07-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000088/0001453687-19-000088-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000096/0001453687-19-000096-index.htm
2019-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000103/0001453687-19-000103-index.htm
2019-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1453687/000145368719000104/0001453687-19-000104-index.htm
2019-08-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000106/0001453687-19-000106-index.htm
2019-08-164/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000110/0001453687-19-000110-index.htm
2019-08-164/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000111/0001453687-19-000111-index.htm
2019-08-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000112/0001453687-19-000112-index.htm
2019-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000120/0001453687-19-000120-index.htm
2019-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000121/0001453687-19-000121-index.htm
2019-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000122/0001453687-19-000122-index.htm
2019-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000123/0001453687-19-000123-index.htm
2019-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000124/0001453687-19-000124-index.htm
2019-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000125/0001453687-19-000125-index.htm
2019-08-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000126/0001453687-19-000126-index.htm
2019-09-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000129/0001453687-19-000129-index.htm
2019-09-053Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000131/0001453687-19-000131-index.htm
2019-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000133/0001453687-19-000133-index.htm
2019-09-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000138/0001453687-19-000138-index.htm
2019-09-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000140/0001453687-19-000140-index.htm
2019-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000145/0001453687-19-000145-index.htm
2019-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000146/0001453687-19-000146-index.htm
2019-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000147/0001453687-19-000147-index.htm
2019-10-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000148/0001453687-19-000148-index.htm
2019-11-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000154/0001453687-19-000154-index.htm
2019-11-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1453687/000145368719000157/0001453687-19-000157-index.htm
2019-11-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000160/0001453687-19-000160-index.htm
2019-11-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000162/0001453687-19-000162-index.htm
2019-11-223Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000165/0001453687-19-000165-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000166/0001453687-19-000166-index.htm
2019-12-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000168/0001453687-19-000168-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368719000171/0001453687-19-000171-index.htm
2020-01-02DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000001/0001453687-20-000001-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000009/0001453687-20-000009-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000010/0001453687-20-000010-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000011/0001453687-20-000011-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000012/0001453687-20-000012-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000013/0001453687-20-000013-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000014/0001453687-20-000014-index.htm
2020-01-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000015/0001453687-20-000015-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000017/0001453687-20-000017-index.htm
2020-01-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000019/0001453687-20-000019-index.htm
2020-03-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000021/0001453687-20-000021-index.htm
2020-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000025/0001453687-20-000025-index.htm
2020-03-1210-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1453687/000145368720000028/0001453687-20-000028-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000030/0001453687-20-000030-index.htm
2020-03-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000033/0001453687-20-000033-index.htm
2020-04-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000038/0001453687-20-000038-index.htm
2020-04-28DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000039/0001453687-20-000039-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000040/0001453687-20-000040-index.htm
2020-04-283Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000042/0001453687-20-000042-index.htm
2020-04-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000044/0001453687-20-000044-index.htm
2020-05-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000050/0001453687-20-000050-index.htm
2020-05-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1453687/000145368720000052/0001453687-20-000052-index.htm
2020-06-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000054/0001453687-20-000054-index.htm
2020-06-10S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000058/0001453687-20-000058-index.htm
2020-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000063/0001453687-20-000063-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000066/0001453687-20-000066-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000067/0001453687-20-000067-index.htm
2020-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000070/0001453687-20-000070-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000076/0001453687-20-000076-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000077/0001453687-20-000077-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000078/0001453687-20-000078-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000079/0001453687-20-000079-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000080/0001453687-20-000080-index.htm
2020-06-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000082/0001453687-20-000082-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000084/0001453687-20-000084-index.htm
2020-08-043Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000089/0001453687-20-000089-index.htm
2020-08-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000090/0001453687-20-000090-index.htm
2020-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000093/0001453687-20-000093-index.htm
2020-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1453687/000145368720000096/0001453687-20-000096-index.htm
2020-08-18DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000099/0001453687-20-000099-index.htm
2020-09-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000103/0001453687-20-000103-index.htm
2020-09-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000104/0001453687-20-000104-index.htm
2020-10-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000106/0001453687-20-000106-index.htm
2020-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000108/0001453687-20-000108-index.htm
2020-10-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000110/0001453687-20-000110-index.htm
2020-10-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000112/0001453687-20-000112-index.htm
2020-10-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000114/0001453687-20-000114-index.htm
2020-10-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000116/0001453687-20-000116-index.htm
2020-10-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000119/0001453687-20-000119-index.htm
2020-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1453687/000145368720000123/0001453687-20-000123-index.htm
2020-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1453687/000145368720000129/0001453687-20-000129-index.htm
2019-09-04DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000156761919017830/0001567619-19-017830-index.htm
2019-03-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000158685219000003/0001586852-19-000003-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1453687/000161577419002515/0001615774-19-002515-index.htm
2019-02-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000167693019000002/0001676930-19-000002-index.htm
2019-03-273Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000167997119000004/0001679971-19-000004-index.htm
2019-03-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000167997119000005/0001679971-19-000005-index.htm
2019-02-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000176022919000002/0001760229-19-000002-index.htm
2019-05-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1453687/000177628419000002/0001776284-19-000002-index.htm
2020-02-06EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1453687/999999999520000281/9999999995-20-000281-index.htm
2020-08-14EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1453687/999999999520002160/9999999995-20-002160-index.htm
2019-04-30CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1453687/999999999719003601/9999999997-19-003601-index.htm
2019-12-13CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1453687/999999999719007872/9999999997-19-007872-index.htm
2019-12-13CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1453687/999999999719007873/9999999997-19-007873-index.htm
2020-05-12CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1453687/999999999720002755/9999999997-20-002755-index.htm

Selecta Biosciences, Inc (SELB) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Selecta Biosciences, Inc (SELB). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 2604%
Institutional Ownership: 6441%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-03-25Elona Esq. KoganGeneral CounselBuy100,000.00100,000.00https://www.sec.gov/Archives/edgar/data/1453687/000167997119000005/0001679971-19-000005-index.htm
2020-10-20TIMOTHY A SPRINGERDirectorBuy910,000.002.212,013,193.0010,836,256.00https://www.sec.gov/Archives/edgar/data/1453687/000145368720000114/0001453687-20-000114-index.htm
2019-07-23Lloyd P. JohnstonCOO and SVP, R&DBuy10,000.000.474,700.0011,606.00https://www.sec.gov/Archives/edgar/data/1453687/000145368719000084/0001453687-19-000084-index.htm
2020-10-21TIMOTHY A SPRINGERDirectorBuy880,000.002.502,199,472.0011,716,256.00https://www.sec.gov/Archives/edgar/data/1453687/000145368720000116/0001453687-20-000116-index.htm
2020-06-24TIMOTHY C BARABEDirectorBuy32,840.001.4647,946.40121,013.00https://www.sec.gov/Archives/edgar/data/1453687/000145368720000084/0001453687-20-000084-index.htm
2020-10-23Takashi Kei KishimotoChief Scientific OfficerBuy30,000.002.7783,100.00126,149.00https://www.sec.gov/Archives/edgar/data/1453687/000145368720000119/0001453687-20-000119-index.htm
2020-10-22TIMOTHY A SPRINGERDirectorBuy1,770,204.002.634,656,698.6413,486,460.00https://www.sec.gov/Archives/edgar/data/1453687/000145368720000116/0001453687-20-000116-index.htm
2019-08-20Stephen SmolinskiChief Commercial OfficerBuy13,812.001.8124,999.7213,812.00https://www.sec.gov/Archives/edgar/data/1453687/000145368719000125/0001453687-19-000125-index.htm
2020-10-23TIMOTHY A SPRINGERDirectorBuy994,488.002.712,699,736.5714,480,948.00https://www.sec.gov/Archives/edgar/data/1453687/000145368720000116/0001453687-20-000116-index.htm
2019-08-20TIMOTHY A SPRINGERDirectorBuy1,100,000.001.811,991,000.001,545,576.00https://www.sec.gov/Archives/edgar/data/1453687/000145368719000126/0001453687-19-000126-index.htm
2020-01-16Lloyd P. JohnstonCOO and SVP, R&DBuy5,128.000.472,410.1616,734.00https://www.sec.gov/Archives/edgar/data/1453687/000145368720000019/0001453687-20-000019-index.htm
2020-10-06TIMOTHY C BARABEDirectorBuy50,000.001.6883,985.00171,013.00https://www.sec.gov/Archives/edgar/data/1453687/000145368720000108/0001453687-20-000108-index.htm
2019-08-13TIMOTHY C BARABEDirectorBuy10,000.001.7217,200.0017,492.00https://www.sec.gov/Archives/edgar/data/1453687/000145368719000106/0001453687-19-000106-index.htm
2019-08-20Elona Esq. KoganGeneral CounselBuy82,872.001.81149,998.32182,872.00https://www.sec.gov/Archives/edgar/data/1453687/000145368719000123/0001453687-19-000123-index.htm
2019-01-25Amir NashatDirectorBuy7,711.001.5011,566.5018,329.00https://www.sec.gov/Archives/edgar/data/1453687/000089924319002116/0000899243-19-002116-index.htm
2019-01-25Amir NashatDirectorBuy11,258.001.5016,887.0026,760.00https://www.sec.gov/Archives/edgar/data/1453687/000089924319002116/0000899243-19-002116-index.htm
2019-01-25Amir NashatDirectorBuy1,125,756.001.501,688,634.002,676,234.00https://www.sec.gov/Archives/edgar/data/1453687/000089924319002116/0000899243-19-002116-index.htm
2019-01-07Takashi Kei KishimotoChief Scientific OfficerBuy36,114.002.77100,035.7836,114.00https://www.sec.gov/Archives/edgar/data/1453687/000167693019000002/0001676930-19-000002-index.htm
2019-08-20Carsten BrunnPresident and CEOBuy41,436.001.8174,999.1641,436.00https://www.sec.gov/Archives/edgar/data/1453687/000145368719000121/0001453687-19-000121-index.htm
2019-08-20Scott Dunseth MyersDirectorBuy41,436.001.8174,999.1641,436.00https://www.sec.gov/Archives/edgar/data/1453687/000145368719000124/0001453687-19-000124-index.htm
2019-01-25TIMOTHY A SPRINGERDirectorBuy4,000,000.001.506,000,000.004,456,597.00https://www.sec.gov/Archives/edgar/data/1453687/000105562419000002/0001055624-19-000002-index.htm
2019-01-25Amir NashatDirectorBuy21,941.001.5032,911.5052,156.00https://www.sec.gov/Archives/edgar/data/1453687/000089924319002116/0000899243-19-002116-index.htm
2019-12-23TIMOTHY A SPRINGERDirectorBuy3,940,887.001.465,753,695.025,486,463.00https://www.sec.gov/Archives/edgar/data/1453687/000110465919076222/0001104659-19-076222-index.htm
2019-08-20PATRICK J ZENNERDirectorBuy55,248.001.8199,998.8855,248.00https://www.sec.gov/Archives/edgar/data/1453687/000145368719000120/0001453687-19-000120-index.htm
2019-08-20TIMOTHY A SPRINGERDirectorBuy1,600,000.001.812,896,000.006,056,597.00https://www.sec.gov/Archives/edgar/data/1453687/000145368719000126/0001453687-19-000126-index.htm
2019-12-23CARRIE SMITH COXDirectorBuy65,681.001.4695,894.2665,681.00https://www.sec.gov/Archives/edgar/data/1453687/000110465919076221/0001104659-19-076221-index.htm
2019-12-02Carsten BrunnPresident and CEOSell14,272.001.5321,809.0470,914.00https://www.sec.gov/Archives/edgar/data/1453687/000145368719000168/0001453687-19-000168-index.htm
2020-10-06TIMOTHY A SPRINGERDirectorBuy2,000,000.001.683,365,800.007,486,463.00https://www.sec.gov/Archives/edgar/data/1453687/000145368720000110/0001453687-20-000110-index.htm
2019-01-25TIMOTHY A SPRINGERDirectorBuy66,666.001.5099,999.0076,418.00https://www.sec.gov/Archives/edgar/data/1453687/000105562419000002/0001055624-19-000002-index.htm
2020-03-03Carsten BrunnPresident and CEOSell3,374.003.8613,011.4978,477.00https://www.sec.gov/Archives/edgar/data/1453687/000145368720000021/0001453687-20-000021-index.htm
2019-12-23Scott Dunseth MyersDirectorBuy39,409.001.4657,537.1480,845.00https://www.sec.gov/Archives/edgar/data/1453687/000110465919076220/0001104659-19-076220-index.htm
2020-10-07TIMOTHY A SPRINGERDirectorBuy654,953.001.651,078,576.608,141,416.00https://www.sec.gov/Archives/edgar/data/1453687/000145368720000110/0001453687-20-000110-index.htm
2020-03-01Carsten BrunnPresident and CEOBuy10,937.0081,851.00https://www.sec.gov/Archives/edgar/data/1453687/000145368720000021/0001453687-20-000021-index.htm
2019-12-23TIMOTHY C BARABEDirectorBuy65,681.001.4695,894.2683,173.00https://www.sec.gov/Archives/edgar/data/1453687/000110465919076223/0001104659-19-076223-index.htm
2019-01-25Omid FarokhzadDirectorBuy83,333.001.50124,999.5083,333.00https://www.sec.gov/Archives/edgar/data/1453687/000158685219000003/0001586852-19-000003-index.htm
2019-12-01Carsten BrunnPresident and CEOBuy43,750.0085,186.00https://www.sec.gov/Archives/edgar/data/1453687/000145368719000168/0001453687-19-000168-index.htm
2019-08-20Takashi Kei KishimotoChief Scientific OfficerBuy50,000.001.8190,500.0086,114.00https://www.sec.gov/Archives/edgar/data/1453687/000145368719000122/0001453687-19-000122-index.htm
2020-06-02Carsten BrunnPresident and CEOSell3,253.003.8612,556.9186,162.00https://www.sec.gov/Archives/edgar/data/1453687/000145368720000054/0001453687-20-000054-index.htm
2019-08-14TIMOTHY A SPRINGERDirectorBuy10,000.001.7417,415.0086,418.00https://www.sec.gov/Archives/edgar/data/1453687/000145368719000112/0001453687-19-000112-index.htm
2020-10-08TIMOTHY A SPRINGERDirectorBuy530,441.001.891,000,836.088,671,857.00https://www.sec.gov/Archives/edgar/data/1453687/000145368720000110/0001453687-20-000110-index.htm
2020-03-17TIMOTHY C BARABEDirectorBuy5,000.002.0010,000.0088,173.00https://www.sec.gov/Archives/edgar/data/1453687/000145368720000030/0001453687-20-000030-index.htm
2020-06-01Carsten BrunnPresident and CEOBuy10,938.0089,415.00https://www.sec.gov/Archives/edgar/data/1453687/000145368720000054/0001453687-20-000054-index.htm
2020-10-09TIMOTHY A SPRINGERDirectorBuy276,703.002.00552,465.218,948,560.00https://www.sec.gov/Archives/edgar/data/1453687/000145368720000112/0001453687-20-000112-index.htm
2020-10-16TIMOTHY A SPRINGERDirectorBuy218,196.002.42528,034.329,166,756.00https://www.sec.gov/Archives/edgar/data/1453687/000145368720000114/0001453687-20-000114-index.htm
2020-09-02Carsten BrunnPresident and CEOSell3,364.002.398,034.5893,735.00https://www.sec.gov/Archives/edgar/data/1453687/000145368720000103/0001453687-20-000103-index.htm
2020-09-01Carsten BrunnPresident and CEOBuy10,937.0097,099.00https://www.sec.gov/Archives/edgar/data/1453687/000145368720000103/0001453687-20-000103-index.htm
2017-11-10TIMOTHY A SPRINGERDirectorBuy4,752.009.0342,905.819,752.00https://www.sec.gov/Archives/edgar/data/1453687/000105562419000002/0001055624-19-000002-index.htm
2020-10-19TIMOTHY A SPRINGERDirectorBuy759,500.002.361,795,002.309,926,256.00https://www.sec.gov/Archives/edgar/data/1453687/000145368720000114/0001453687-20-000114-index.htm